Abstract LB-162: Causal role of body mass index in lung cancer in mendelian randomization analysis accounting for genetic pleiotropism
Authors: Yiqun Wu, Jee-Young Moon, Christopher I. Amos, Rayjean J. Hung, Gloria Y. Ho, Tao Wang
Journal: Cancer Research (2018)

Abstract Background: Body mass index (BMI) is inversely associated with lung cancer in observational studies, despite obesity increases risk for many other cancers. Mendelian Randomization (MR) analysis was previously employed to clarify the causal role of BMI in lung cancer. However, the results of MR were potentially biased by BMI-SNPs with pleiotropic effects on smoking and hence violating the assumption of MR. Objective: To examine the causal role of BMI in lung cancer using MR analysis after excluding BMI-SNPs with potential pleiotropic effects on smoking. Methods: The OncoArray data from the Transdisciplinary Research in Cancer of the Lung (TRICL) team of the International Lung Cancer Consortium (ILCCO) were used. To obtain a valid genetic instrument for MR analysis, we first identified a set of 241 BMI-SNPs (P&amp;lt;10-5) from the GIANT consortium, then filtered out SNPs with potential pleiotropic effects on smoking using causal network inference, and obtained a final set of 46 SNPs to calculate the genetic risk score for BMI (GRS46). Logistic regression model tested its association with lung cancer adjusting for age, sex, and genetic principle components. We compared results of GRS46 with those from GRS241 that included pleiotropic SNPs. Results: A total of 32,240 subjects of European descent (17,976 lung cancer cases and 14,264 controls) were included in the analysis. The average age was 63.0 (SD: 10.5) years, 61.2% were male, 59.5% were overweight (BMI: 25.0-29.9 kg/m2) or obese (BMI≥30 kg/m2), and 79.3% were ever smokers. GRS46 was positively associated with lung cancer (OR: 1.57, 95% CI: 1.20-2.07) in both never smokers (OR: 2.18, 95% CI: 1.10-4.31) and ever smokers (OR: 1.40, 95% CI: 1.02-1.92). GRS46 was significantly associated with increased risk of non-small cell lung cancer (OR: 1.69, 95% CI: 1.21-2.36), adenocarcinoma (OR: 1.76, 95% CI: 1.19-2.60), and squamous cell carcinoma (OR: 1.98, 95% CI: 1.18-3.33), but not with small cell lung cancer (SCLC) (OR: 1.29, 95% CI: 0.63-2.64). In contrast, GRS241 was significantly associated with SCLC (OR: 1.57, 95% CI: 1.21-2.05), which is highly attributable to smoking, but not associated with lung cancer subgroups that are not or less attributable to smoking: never smokers (OR: 1.00, 95% CI: 0.78-1.29) and adenocarcinoma (OR: 1.07, 95% CI: 0.92-1.24). The pleiotropic smoking-associated SNPs in GRS241 might have confounded the results in these subgroups. Conclusion: Increased BMI is a risk factor for lung cancer in both never and ever smokers and for major histological subtypes after accounting for genetic pleiotropism. We demonstrated that previous MR analyses that used a BMI-GRS including SNPs with pleiotropic effects on smoking could yield spurious results. Funding: This work was support by R21 CA202529 (Wang/Ho). Confirmation: These data were not published previously and will not publish prior to the dates of the AACR Annual Meeting 2018. Citation Format: Yiqun Wu, Jee-Young Moon, Christopher I. Amos, Rayjean J. Hung, Gloria Y. Ho, Tao Wang. Causal role of body mass index in lung cancer in mendelian randomization analysis accounting for genetic pleiotropism [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr LB-162.